27154 Federal Register / Vol. 74, No. 108 / Monday, June 8, 2009 / Notices 

2002–2004 of 5.93% increase to 12.54% 

for 2005–2007. 

The reduction in the earlier years IMR 

(2002–2004) for Central Harlem made 

them ineligible for the FY 2009 Healthy 

Start Eliminating Disparities Open 

competition. To be eligible, the IMR for 

the service area had to be 1.5 times the 

national average for the period of 2002– 

2004 or 10.35. In FY 2010 there will be 

another Healthy Start Eliminating 

Disparities Open competition and 

grantees will be required to the use the 

most recently available IMR data (2004– 

2006 or 2005–2007) to compete. To be 

eligible for the competition, grantees 

will have to have an IMR that is 1.5 

times the national average for the 

project area for either 2004–2006 or 

2005–2007. Data supplied the New York 

City Bureau Statistics indicates that 

Central Harlem would be eligible for 

this competition because they have 

12.54% IMR for teen births for 2005– 

2007. 

The award of non-competitive 

supplemental funding will enable 

NMPP to provide much need services in 

Central Harlem. Given the current 

economic situation and the rising IMR 

rate in the project area, the loss of this 

experienced provider of health services 

would be devastating and would 

contribute to the rise in infant deaths in 

Central Harlem, NMPP is the primary 

provider of comprehensive communitybased perinatal services and the only 

Healthy Start site serving the project 

area. The project’s dedication and 

commitment to the residents of Harlem 

since 1999 could not be replaced 

another community based provider. 

FOR FURTHER INFORMATION CONTACT: John 

McGovern, Public Health Analyst, 

Division of Healthy Start and Perinatal 

Services, Maternal and Child Health 

Bureau, HRSA, Room 18–12, Parklawn 

Building, 5600 Fishers Lane, Rockville, 

MD 20857; phone 301–443–5805; E-mail 

jmcgovern@hrsa.gov. 

Dated: May 29, 2009. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. E9–13279 Filed 6–5–09; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel Competitive Revision—ARRA Funds. 

Date: June 11, 2009. 

Time: 1:45 p.m. to 3:45 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, Room 3AN18, 45 Center 

Drive, Bethesda, MD 20892. (Telephone 

Conference Call). 

Contact Person: Rebecca H Johnson, PhD, 

Scientific Review Administrator, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, Natcher Building, Room 3AN18C, 

Bethesda, MD 20892. 301–594–2771. 

johnsonrh@nigms.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives; 93.701, ARRA 

Related Biomedical Research and Research 

Support Awards, National Institutes of 

Health, HHS) 

Dated: June 1, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13199 Filed 6–5–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel—Program Project. 

Date: July 10, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIH, Democracy II, 6701 Democracy 

Plaza II, 200, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: John K. Hayes, PhD, 

Scientific Review Officer, 6707 Democracy 

Boulevard, Suite 959, Bethesda, MD 20892, 

301–451–3398, hayesj@mail.nih.gov. 

Dated: June 1, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13282 Filed 6–5–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel. Animal Models of Infectious 

Diseases 1. 

Date: June 29–July 1, 2009. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Crowne Plaza—Silver Spring, 8777 

Georgia Avenue, Silver Spring, MD 20910. 

Contact Person: Tracy A. Shahan, PhD, 

MBA, Scientific Review Officer, Scientific 

Review Program, NIH/NIAID/DHHS, Room 

3121, 6700B Rockledge Drive, MSC 7616, 


cprice-sewell on PRODPC61 with NOTICES